1. Home
  2. AXR vs SGMO Comparison

AXR vs SGMO Comparison

Compare AXR & SGMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXR
  • SGMO
  • Stock Information
  • Founded
  • AXR 1961
  • SGMO 1995
  • Country
  • AXR United States
  • SGMO United States
  • Employees
  • AXR N/A
  • SGMO N/A
  • Industry
  • AXR Homebuilding
  • SGMO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • AXR Real Estate
  • SGMO Health Care
  • Exchange
  • AXR Nasdaq
  • SGMO Nasdaq
  • Market Cap
  • AXR 114.8M
  • SGMO 122.8M
  • IPO Year
  • AXR N/A
  • SGMO 2000
  • Fundamental
  • Price
  • AXR $23.85
  • SGMO $0.50
  • Analyst Decision
  • AXR
  • SGMO Buy
  • Analyst Count
  • AXR 0
  • SGMO 6
  • Target Price
  • AXR N/A
  • SGMO $4.50
  • AVG Volume (30 Days)
  • AXR 14.7K
  • SGMO 5.2M
  • Earning Date
  • AXR 09-12-2025
  • SGMO 08-05-2025
  • Dividend Yield
  • AXR N/A
  • SGMO N/A
  • EPS Growth
  • AXR 472.07
  • SGMO N/A
  • EPS
  • AXR 2.41
  • SGMO N/A
  • Revenue
  • AXR $58,052,000.00
  • SGMO $63,756,000.00
  • Revenue This Year
  • AXR $120,108.69
  • SGMO N/A
  • Revenue Next Year
  • AXR $8.16
  • SGMO N/A
  • P/E Ratio
  • AXR $9.82
  • SGMO N/A
  • Revenue Growth
  • AXR 30.35
  • SGMO 239.92
  • 52 Week Low
  • AXR $17.60
  • SGMO $0.37
  • 52 Week High
  • AXR $39.68
  • SGMO $3.18
  • Technical
  • Relative Strength Index (RSI)
  • AXR 68.04
  • SGMO 43.92
  • Support Level
  • AXR $22.71
  • SGMO $0.50
  • Resistance Level
  • AXR $25.01
  • SGMO $0.54
  • Average True Range (ATR)
  • AXR 1.06
  • SGMO 0.04
  • MACD
  • AXR 0.26
  • SGMO -0.00
  • Stochastic Oscillator
  • AXR 74.18
  • SGMO 29.35

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About SGMO Sangamo Therapeutics Inc.

Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.

Share on Social Networks: